tbuckley/cabot-search huggingface dataset:
P2.10A.02 Phase 1/1b Trial of MBRC-101, An Anti-EphA5 Monomethyl Auristatin (MMAE) Antibody Drug Conjugate, In Advanced Refractory Solid Tumors
Authors: M. Gubens, S. Sen, M.A. Salkeni, A. Vandross, N. Gandhi, W.J. Edenfield, R. Aggarwal, K. Parsons, I. Chen, J. Powderly
Journal: Journal of Thoracic Oncology (2024)
P4.07D.04 Trofuse-019: A Phase 3 Study of Adjuvant Pembrolizumab with or without Sac-TMTfor Resectable Stage II-IIIB (N2) NSCLC
Authors: J.M. LEE, B.-C. Liao, J. Spicer, T. Newsom-Davis, R. Hui, Y. Xu, A. Song, A. Samkari, M. Hochmair
Journal: Journal of Thoracic Oncology (2024)
P2.07B.09 Real-World Validation for Impact of Sublobar Resection Over Lobectomy on Lung Cancer Survival and Frailty Using SEER-Medicare
Authors: E. Choi, C.C. Su, Y. Shi, L.K. Groner, B.B. Pua, R. Crupi, J. Mao, H.-Y. Jung, C.A. Garcia, L.C. Pinheiro, E.T. Sholle, Y. Shieh, R. Tamimi, A. Sedrakyan, S.S. Han, N. Altorki, J. Mandelblatt
Journal: Journal of Thoracic Oncology (2024)
P2.04B.05 Engaging Culturally and Linguistically Diverse Communities to Prepare for Lung Cancer Screening Implementation in Australia
Authors: S. York, M.L. Yap, J. Rhee, L. Pitts, J.P. Troiani, B. Stanoevska, N. Harrison, R. Dodd, A. McWilliams, H. Marshall, E. Stone, N. Rankin
Journal: Journal of Thoracic Oncology (2024)
P1.13A.01 DeLLphi-306 Trial: A Phase 3 Study of Tarlatamab after Concurrent Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer
Authors: A. Dowlati, H.-D. Hummel, L. Paz-Ares, F. Blackhall, A. Chiang, J. Goldman, H. Izumi, T. Mok, J. Sands, P. Martinez, E.S. Anderson, A. Hamidi, B. Yu, Y. Yu, M. Provencio
Journal: Journal of Thoracic Oncology (2024)
P1.12A.13 When Targeted Therapy Targets the Heart: Osimertinib-related Cardiotoxicity in EGFR Mutated Non-Small Cell Lung Cancer
Authors: F.J. Martinez, R. Liu, S. Zhu, L. Sakoda, C. Goh, V. Ropko, V. Sarovar, M. Suga
Journal: Journal of Thoracic Oncology (2024)
P2.04B.11 Factors Associated with Early-Stage Lung Cancer Diagnosis (ESLCD) In Brazil - 2013 - 2019: A Multivariable Analysis
Authors: I. Emmerick, M. Campos, D. Castanheiras, L. Vinhal Faria, T. Sequeira Valerio, A. Marques, J. Muzy, L. Arueira Chaves, M.J. Sobreira da Silva
Journal: Journal of Thoracic Oncology (2024)
P2.04A.04 The Lung Health Check Pilot: Ireland's Flagship Lung Cancer Screening Trial
Authors: D.E.O. Reilly, S. Roche, S. Toomey, B. Hennessy, G.J. Fitzmaurice, K. Egan, C. Dowling, I. Counihan, E.O. Brien, I. Sulaiman, R. Morgan, C. Noonan, B. Jacob, A.-M. Baird, S. Cotter, K. Bennett, J. Sorensen, J. Ryan, P. Redmond, D.J. Ryan, J. Naidoo
Journal: Journal of Thoracic Oncology (2024)
P2.07A.05 Synchronous Super Multiple Primary Lung Cancers Prefer High-Frequency BRAF and Low-Frequency EGFR Mutations in MAPK Pathway
Authors: H. Li, Z. Huang, C. Guo, Y. Wang, S. Wang, N. Bai, N. Liang, S. Li
Journal: Journal of Thoracic Oncology (2024)
P2.07B.01 Single Versus Multiple Segmentectomies: A Comparison of Short- And Long-Term Outcomes
Authors: F. Pezeshkian, M. McAllister, F. Hooshmand, A. Singh, J. Herrera-Zamora, R. Leo, E. Sugarbaker, R. Ribeiro Barcelos, M.M. Rochefort, H.A. Khalil, R. Bueno, P.A. Ugalde Figueroa, M.T. Jaklitsch, S.J. Swanson
Journal: Journal of Thoracic Oncology (2024)
P2.05B.01 How Reliable Is PET/CT in T1A and T1B Non-Small Cell Lung Cancer for Mediastinal Staging?
Authors: G. Özcibik Isik, None &. Sarbay, B. Kiliç, E. Erşen, V. Kara, M.K. Kaynak, A. Turna
Journal: Journal of Thoracic Oncology (2024)
P2.05B.02 Automated Extraction of Key Entities from Thorax CT Reports Using NER with Prompt Engineering
Authors: Z. Akcali, M. Kocak, A. Farzaliyeva, F. Guven, M.N. Ramazanoglu, E. Hasdemir, B. Yagdiran, A. Oguz, M. Agildere, O. Altundag
Journal: Journal of Thoracic Oncology (2024)
P1.13A.07 Real-World First-Line Serplulimab-Based Immunochemotherapy for Extensive-Stage Small Cell Lung Cancer: The Multicenter ASTRUM-005R Study
Authors: L. Wu, C. Hu, W. Su, Y. Yu, W. Hong, Z. Liu, H. Su, Z. Liu, C. Wang, Q. PU, H. Guo, X. Min, Y. Chen, H. Zhu, T. Luo
Journal: Journal of Thoracic Oncology (2024)
P4.07E.02 Genomic Profiling of Pre-invasive and Early-Stage Lung Adenocarcinoma Delineates Gene Signatures of Different Adenocarcinoma Subtypes
Authors: Y.-H. Luo, H.-C. Huang, C.-J. Huang, C.-L. Chiang, H.-S. Hsu, Y.-C. Yeh, Y.-C. Wang, Y.-M. Chen
Journal: Journal of Thoracic Oncology (2024)
P1.13A.03 MOZART: Phase II Trial of Monalizumab, Durvalumab, and Platinum-based Chemotherapy for First-Line Treatment of Extensive Stage SCLC
Authors: H. Mamdani, S. Kim, R. Gentzler, M. Furqan, M.D. Shields, S.I. Jalal
Journal: Journal of Thoracic Oncology (2024)
P2.04B.08 Terminology in Lung Cancer Screening and Early Detection - IASLC Early Detection and Screening Committee Recommendations
Authors: R.M. Huber, M. Cavic, H. Balata, A. Borondy-Kitts, J. Field, C. Henschke, E.A. Kazerooni, A. Kerpel-Fronius, R. Smith, E. Taioli, L. Ventura, S. Lam, D. Yankelevitz, M. Tammemägi
Journal: Journal of Thoracic Oncology (2024)
P1.13A.02 Tarlatamab Plus Durvalumab as First-Line Maintenance in Extensive-Stage Small Cell Lung Cancer: DeLLphi-305 Phase 3 Trial
Authors: M. Perol, M.-J. Ahn, Y. Cheng, J. Clarke, A.-M. Dingemans, C. Gay, A. Navarro, M. Schuler, T. Yoshida, P. Martinez, E.S. Anderson, J. Sands
Journal: Journal of Thoracic Oncology (2024)
P1.13A.10 Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study
Authors: B. Halmos, P. Lammers, G. Liu, L. Shunyakov, S. Madden, S. Kassam, M. Patel, Y. Ji, C. Labbé, N. Naveh, C. Ndibmun, W. Li, B. Rengarajan, F. Badin
Journal: Journal of Thoracic Oncology (2024)
P1.12A.04 Socioeconomic Disparities and Overall Survival Differences Among Ethnic-Minority Patients with EGFR-Mutated NSCLC Treated with Osimertinib
Authors: M. Lee, E. Miao, C. Zhang, X. Xue, S. Tuckman, N. Ohri, B. Halmos, H. Cheng
Journal: Journal of Thoracic Oncology (2024)
P2.04B.01 Argentine Lung Cancer Screening Programes Collaborative Registry: The LuCaS.Ar Project
Authors: I. Boyeras Navarro, S. Defranchi, S. Lamot, J.L. Morero, L. Cuper, K. Patane, R. Pendino, M. Pascuccio, L. Vegetti, M. Hernandez, S. Benitez, A. Videla, R. Re, L. Paganini
Journal: Journal of Thoracic Oncology (2024)
P2.04B.04 Harnessing EHR/IT to Accelerate Lung Cancer Screening - An American Cancer Society National Lung Cancer Roundtable Initiative
Authors: L.S. Rosenthal, C.C. Thomson, D.S. Dyer, T.J. Caverly, G.L. Branford, N.T. Tanner, C.G. Slatore, P.J. Mazzone, N. Irani, J.T. Fathi, R.A. Smith, E.A. Kazerooni
Journal: Journal of Thoracic Oncology (2024)
P1.12B.08 Thrombotic Events at Diagnosis are Associated with Poorer First Line TKI Outcomes Among Metastatic ALK and ROS1 NSCLC Patients
Authors: M. Sakamoto, J. Hu, V. Alami, A. Watson, R. Camidge, E. Schenk, P.A. Bunn, S. Pine, T. Patil
Journal: Journal of Thoracic Oncology (2024)
P2.04B.07 Impact of Primary Care Initiated Lung Cancer Screening Program: The VANCHCS Experience
Authors: G. Kaleka, D. Liu, B. Guan, E.R. Thomas, S. Chen, L. Strokecker, J. Brown-Lambey, S.K. Shenoy, B.M. Morrissey, N.M. Stollenwerk, C.T. Phan, D. Cheng, R.J. Knebel, L.A. Godoy, S. Zanfardino, P. Rajappa, T. Li
Journal: Journal of Thoracic Oncology (2024)
P2.04B.02 Eight Year Outcomes of a Multidisciplinary Lung Cancer Screening Program at a Large Community Centre in Canada
Authors: M. Ossip, G. Sharma, D. Levay, A. Bendzsak, K. Irshad, C. Yeung, K. Bisson, L. Vicente, K. Perdrizet, B. Sheffield, P.K. Cheema
Journal: Journal of Thoracic Oncology (2024)
P1.12B.07 Iruplinalkib in Patients with ALK-Positive Crizotinib-Resistant NSCLC: Updated Efficacy and Safety Data from a Phase 2 Trial
Authors: Y. Shi, J. Chen, H. Zhang, Z. Zhang, Y. Zhang, Z. Wang, S. Zhang, J. Zhao, C. Liu, X. Wang, Y. Zhao, C. Hu, L. Yang, X. Hao, L. Wang, Y. Liu, Y. Yu, J. Zhao, M. Wang, L. Zhang, S. Sun, Y. Hu, K. Gu, X. Hang, J. Shan, Y. Zhang, B. Tan, W. Yang, R. Yang, M. Si, H. Li, X. Kang
Journal: Journal of Thoracic Oncology (2024)
P1.08D.03 Induction Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-Small Cell Lung Cancer (NSCLC)
Authors: R.E. Sanborn, D. Hanes, D. Shaker, M.J. Fidler, S. Gurubhagavatula, S.-C. Chang, W.L. Redmond
Journal: Journal of Thoracic Oncology (2024)
P1.12B.04 Central Nervous System (CNS) Progression on CNS Penetrable ALK TKI: Real-World Practice Patterns and Patient Outcomes
Authors: S. Singhal, C. Hui, J. Neal, M. Roy, M. Das, K. Ramchandran, E. Pollom, G. Selvaggi, H. Wakelee, N. Myall
Journal: Journal of Thoracic Oncology (2024)
P2.04A.06 A Multilevel Approach to Address Disparities in Lung Cancer Screening: The PREP Trial
Authors: R.M. Williams, K.L. Taylor, G. Luta, A. Sangraula, P. Yee, S. Melvin, T. Lobo, J. Blumenthal, S. Mathur, K. Miller, L. Adams-Campbell, K. Foley, K. Lin
Journal: Journal of Thoracic Oncology (2024)
P1.08D.04 The Clinical Outcomes of Contralateral Esophagus Sparing IMRT in Concurrent Chemoradiotherapy for Stage III Lung Cancer
Authors: H. LIM, K. Yang, J.M. Noh, H. Pyo, D.Y. Kwon, J.M. Kim, S.G. Ju, Y.C. Ahn
Journal: Journal of Thoracic Oncology (2024)
P1.13A.06 Outcomes in LS SCLC Patients with Severe Acute Esophagitis During Chemotherapy and Concurrent Twice-Daily Thoracic Radiotherapy
Authors: M. Grønberg, T.O. Halvorsen, B.H. Grønberg, K.T. Killingberg, M. Aanerud
Journal: Journal of Thoracic Oncology (2024)
P1.12A.09 A Phase 1b Study of the MER Tyrosine Kinase Inhibitor, MRX-2843, in Combination with Osimertinib in Advanced EGFR Mutant Non-Small Cell Lung Cancer
Authors: C. Steuer, J. Carlisle, T. Leal, F. Ardeshir, M. Holmes, F. Schneider, Z. Chen, J. Switchenko, J. Ross, G. Selvagi, T. Owonikoko, s. ramalingam
Journal: Journal of Thoracic Oncology (2024)
P1.13A.05 Preliminary Results of A Phase II Study of Camrelizumab Combined with Chemotherapy Followed by Concurrent Chemoradiotherapy for LD-SCLC
Authors: M. Hu, Y. Zhu, J. Kang, Y. Chen, X. Xu, Q. Xu, J. Ni, Y. Xu
Journal: Journal of Thoracic Oncology (2024)
P1.12A.12 Liquid Biopsy Based Risk Stratification and Intensification of Treatment in EGFR Mutant Advanced NSCLC (L-BRITE) Preliminary Analysis
Authors: H. baskarane, P.S. Malik, D. Jain, S. Khurana, D. Pushpam, S.K.U.M.A.R. Singla
Journal: Journal of Thoracic Oncology (2024)
P1.13A.11 Patterns of Disease Progression after Atezolizumab Plus Chemotherapy in ES-SCLC: Exploratory Analysis from IMfirst Study
Authors: R. García-Campelo, M. Dómine Gómez, J. de Castro, A. Moreno Vega, S. Ponce Aix, E. Arriola, E. Carcereny, M. Majem, G. Huidobro Vence, E. Esteban González, J. Fuentes Pradera, A.L. Ortega Granados, M. Guillot Morales, B. Massuti Sureda, N. Fernández Núñez, M. Provencio, N. González-Mancha, C.A. Fajardo, N. Lerones, M. Cobo Dols
Journal: Journal of Thoracic Oncology (2024)
P1.12B.09 Efficacy of Selpercatinib by RET Fusion Partner in RET+ NSCLC: Results from the LIBRETTO-001 and LIBRETTO-431 Trials
Authors: B. Solomon, A. Drilon, K. Park, S. Novello, E. Nadal, B. Besse, N. Peled, P. Peterson, S. Barker, A. Szpurka, O. Grbovic-Huezo, H. Loong
Journal: Journal of Thoracic Oncology (2024)
P1.13A.09 RYZ101 (225Ac-DOTATATE) + Carboplatin + Etoposide + Atezolizumab in Somatostatin Receptor Expressing Extensive-Stage Small-Cell Lung Cancer
Authors: S. Puri, W. Akerley, R. Langdon, S. Mehr, N. Rivera-Rodriguez, J. Berilgen, J.M. Rineer, C. Mulvey, K. Howell, A.S. Mansfield, E. Parent, M. Thakur, B. Mancini, J. Goldman, J. Calais, D. Bushnell, Y. Yuan, J. Li, N. Pascale, L. Gong, D. Ferreira, Z. Hao
Journal: Journal of Thoracic Oncology (2024)
P1.06C.04 Low-Level Deletion of Chromosome 19p Genes May Be Sufficient to Drive Histology-Dependent Phenotypes in Lung Cancer
Authors: B. Henick, S. Mallick, N. Zhakula-Kostadinova, Y. Georgis, B. Herzberg, C. Concepcion-Crisol, A.M. Taylor
Journal: Journal of Thoracic Oncology (2024)
P1.06B.14 Optimal Cut-Off with NGS for Metamplification Andclinical Relevance to MET Inhibitor in Non-Small-Cell Lung Cancer
Authors: S.-Y.M. Liu, Z. Xie, L. Yan, G.-L. Jie, J.-Y. Deng, Q. Zhang, Z. Huang, J. Wang, Z. Zhang, Y. Shao, H. Meng, Y. Zhang, X.-C. Zhang, W.-Z. Zhong, Q. Zhou, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2024)
P1.09B.05 Improved Survival of Primary Tumor Resectionfor Metastatic Non Small Cell Lung Cancer:a Propensity Score-matched Analysis
Authors: J. Wu, F. Qin, X. Qin, Y. Zheng, H. Zheng, J. Chen, Z. Liu, B. Jian, G. Wang, H. Liao
Journal: Journal of Thoracic Oncology (2024)
P1.06B.11 Plasma MicroRNAs Profiling to Monitor Immunotherapy Response in Advanced NSCLC Patients
Authors: C. Proto, M.V. Chiaruttini, A. Zanghì, G. Lo Russo, A. Prelaj, M. Segale, F.G. Greco, M. Brambilla, M. Occhipinti, T. Beninato, L. Mazzeo, R. Leporati, M. Ganzinelli, C. Giani, D. Miliziano, G. Di Liberti, G. Mazzoli, F. De Braud, M.C. Garassino, G. Sozzi, E. Rulli, M. Boeri
Journal: Journal of Thoracic Oncology (2024)
P1.06A.03 Use of Biosimulation to Predict Concomitant Chemotherapy Benefit in NSCLC Patients with EGFR Mutations Being Treated with Osimertinib
Authors: C. Aggarwal, J.A. Wingrove, S. Kapoor, S. Khandelwal, A. Ambreen, Y.S. Ullal, A. Ghosh, P. Kumari, N. Gupta, A. Kumar, M. Castro, T. Patil
Journal: Journal of Thoracic Oncology (2024)
P1.06A.02 Discovery of Morphomolecular Neighbourhoods in Lung Adenocarcinoma Using Self-supervised Learning
Authors: K. Rakovic, F. Ballantyne, S. Martinelli, L. Officer-Jones, R. Pennie, I. Powley, K. Yuan, J. Le Quesne, N. Poulain, C. Ficken
Journal: Journal of Thoracic Oncology (2024)
P1.09B.02 Double Lung Transplantation in Patients with Metastatic Lung-limited Non-Small Cell Lung Carcinoma (NSCLC)
Authors: Y.K. Chae, T. Demir, L.I.-Y. Chung, W. Woo, C. Moloney, B. Sanson, R. Dwyer, C.M. Jung, R. Tomic, A. Bharat
Journal: Journal of Thoracic Oncology (2024)
P1.06A.05 Assessing Pathologic Response to Neoadjuvant Chemoimmunotherapy for NSCLC: Aligning Current Protocols with Artificial Intelligence
Authors: E. Conde, D. Curto, S. Hernandez, M. Alonso, V. Adradas, M. Peressini, L. Paz-Ares, J. Zugazagoitia, F. Lopez-Rios
Journal: Journal of Thoracic Oncology (2024)
P1.08B.02 Circulating T-Cell Immunosenescence in Patients with Unresectable Locally Advanced NSCLC: Preliminary Results of the SENLOAD Study
Authors: J.C. Benítez, M.v. SANCHEZ-BECERRA, N. Chaput, M. Naigeon, L. Cassard, L. Girard, D. Korera, N. Cozic, P. Lavaud, P. Abdayem, V. Albarragan-Artahona, A. Botticella, D. Planchard, J. Remon, F. Barlesi, C. Le Pechoux, B. Besse, A. Levy
Journal: Journal of Thoracic Oncology (2024)
P1.08B.01 Predicting Tumor Recurrence Risk in Locally Advanced NSCLC with Detectable ctDNA-Based Molecular Residual Disease: An Xgboost Model Analysis
Authors: Y. Pan, J.-T. Zhang, X. Gao, Z.-C. Jiao, Z.-Y. Chen, H. Lin, S.-Y.M. Liu, L.-B. Tang, H.-H. Yan, S. Dong, H.-J. Chen, B.-C. Wang, H.-Y. Tu, X.-N. Yang, J.-J. Yang, W.-Z. Zhong, Q. Zhou, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2024)
P1.08D.02 Survival after Salvage Treatment Following Durvalumab Consolidation in Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
Authors: M. Stalker, M. Marmarelis, C. Langer, R.B. Cohen, A. Singh, C. Aggarwal, L. Sun
Journal: Journal of Thoracic Oncology (2024)
P1.12A.06 A Phase II 80 Mg Osimertinib in Patients with Leptomeningeal Metastases Associated with EGFR Mutation-Positive NSCLC (BLOSSOM)
Authors: S. Park, R. Baldry, H.A. Jung, J.-M. Sun, S.-H. Lee, J.S. Ahn, Y.J. Kim, Y. Lee, D.-W. Kim, S.-W. Kim, K.H. Lee, W.J. Lee, J.W. Choi, K. Chong, J.-I. Lee, S.-H. Gwon, N.-H. Son, M.-J. Ahn, J. Kim
Journal: Journal of Thoracic Oncology (2024)
P1.03D.09 Single Cell RNA Sequencing and Functional Monocyte Stimulation Reveals Phenotypic Predispositions to Developing Lung Cancer in Never Smokers
Authors: V. Chin, R.A. McCloy, A. Sennabouth, D. Neavin, H. Arora, M. Boyer, J. Simes, A. Joshua, B. Brown, J. Powell
Journal: Journal of Thoracic Oncology (2024)
P1.03D.11 Association Between Plasminogen Activator Inhibitor-1 &amp; Tolerance Against Anti-PD-1 Antibody in Non-Small Cell Lung Cancer
Authors: M. Sumii, T. Masuda, K. Shimoji, K. Yamaguchi, S. Sakamoto, Y. Horimasu, T. Nakashima, H. Iwamoto, H. Hamada, N. Hattori
Journal: Journal of Thoracic Oncology (2024)
P1.03G.04 A Model of Human Small Cell Lung Cancer Metastasis Utilizing Orthotopic Transplantation of Patient-Derived Xenografts
Authors: J. Kim, S. Pal Chadhouri, K. May, T. Salisbury, C. Suchors, B. Freitas, S. Hamilton, V. Chien, L. Girard, M.S. Lawrence, B.S. Drapkin
Journal: Journal of Thoracic Oncology (2024)
P1.08C.01 Targeted Therapy or Chemotherapy as Neoadjuvant Treatment for Resectable Stage II-IIIB EGFRm Lung Adenocarcinoma: A Study Between Four Cohorts
Authors: F.-L. Lu, C. Lv, X. Yang, M.L. Zhuo, N. Wu
Journal: Journal of Thoracic Oncology (2024)
P1.01A.03 Can-Prevent-Lung Trial-Canakinumab for the Prevention of Lung Cancer: Updated Interim Clinical and Biomarker Analysis
Authors: J.J. Zhang, M. Salehjahromi, S. Heeke, M. Godoy, H. Tran, M. Antonoff, B. Carter, E. Ostrin, X. Le, C. Gay, M. Vailati Negrao, L. Byers, C. Lu, G. Blumenschein, D. Rice, G. Walsh, R. Rajaram, S. Lin, W. Hofstetter, R. Mehran, A. Vaporciyan, S. Moghaddam, J.J. Lee, J. Wu, J. Heymach
Journal: Journal of Thoracic Oncology (2024)
P1.03A.02 FBXO32 Promotes EMT and Regulates the Cell Cycle by Targeting PTEN for Proteasomal-Dependent Degradation in LUAD
Authors: J. Wu, T. Wen, A. Marzio, D. Song, S. Chen, C. Yang, F. Zhao, H. Ren, Q. Chen, Y. Yang, S. Qin
Journal: Journal of Thoracic Oncology (2024)
P1.03D.08 Padeliporphin VTP Reverts NSCLC Orthotopic Tumors in Animal Models Into Highly Responsive to aPD1 Therapy
Authors: D. Kain, L. Agemy, K. Sasson, I. Biton, T. Yechezkel, A. Scherz
Journal: Journal of Thoracic Oncology (2024)
P1.03D.01 Efficacy and Biomarker Analysis of Neoadjuvant Toripalimab Plus Chemotherapy in Resectable Stage IIB-IIIB Non-Small Cell Lung Cancer (NSCLC)
Authors: B. Liu, N. Wu, S. Yan, E. Zhang, L. Xu, X. Cheng
Journal: Journal of Thoracic Oncology (2024)
P1.06A.06 Post-COVID-19 Tumor Microenvironment Features and AI-Based Evaluation in KRAS-Mutant NSCLC
Authors: Z. Huang, L. Li, S. Wang, Z. Peng, Y. Jia, J. Zhang, Q. He, S. Zeng, B. Yang, Y. He, T. Guan, Y. Li
Journal: Journal of Thoracic Oncology (2024)
P1.03F.02 Establishment of EBUS-TBNA Sample Derived Lung Cancer Organoid and Xenograft and Utility for Development of Targeted Therapy
Authors: T. Koga, H. Ogawa, N. Radulovich, N.-A. Pham, M. Li, Y. Wang, Y. Sata, S. Kitazawa, Y. Hiraishi, T. Ishiwata, A. Effat, K. Kazlovich, F. Yokote, T. Yanagihara, K. Nakahashi, Y. Fujibayashi, N. Bernards, M.-S. Tsao, K. Yasufuku
Journal: Journal of Thoracic Oncology (2024)
P1.06B.08 The Prognostic Value of Histidine-rich Glycoprotein in Patients with Bronchial Carcinoid
Authors: D.D. Naves, E. Reuling, T. van Ee, C. Ariño Palao, C. Jimenez, Y. van Kooyk, C. Dickhoff, J. Daniels, F. Böttger, T. Radonic
Journal: Journal of Thoracic Oncology (2024)
MA16.07 A First in Human (FIH), Phase 1 Open Label, Dose Escalation and Expansion Study of CTM103, a LNP MRNA Encoding an IL2Rß? Selective Il-2v, As Monotherapy and in Combination with Pembrolizumab, in Patients with Advanced Solid Tumors
Authors: C. Kong, J. Zhang, L. Sun, Q. Xuan, H. Huang, K. Wang
Journal: Journal of Thoracic Oncology (2024)
MA19.03 SMARCA4 Controls State Plasticity in SCLC Through Regulation of Neuroendocrine Transcription Factors and REST Splicing
Authors: E. Redin, H. Sridhar, Y. Zhan, B. Pereira Mello, H. Zhong, P. Manoj, I. Linkov, J. Qiu, R.P. Koche, E. de Stanchina, A. Quintanal-Villalonga, C.M. Rudin
Journal: Journal of Thoracic Oncology (2024)
MA18.13 Comparison of Sybil with Brock and PLCOm2012 Models Among Screening Participants with Positive and Negative Baseline Screens
Authors: R. Meza, C. Durney, Y. Mok, S. Atkar-Khattra, R. Phellan Aro, M.T. Warkentin, M. Tammemagi, R. Myers, R.J. Hung, S. Lam
Journal: Journal of Thoracic Oncology (2024)
P1.01B.02 The Genomic Landscape of Lung Cancer in Never-Smokers from the Women's Health Initiative
Authors: S. Moorthi, A. Paguirigan, P. Itagi, M. Ko, M. Pettinger, A.C.H. Hoge, A. Nag, N.A. Patel, F. Wu, C. Sather, K.M. Levine, M.P. Fitzgibbon, A.R. Thorner, G.L. Anderson, G. Ha, A.H. Berger
Journal: Journal of Thoracic Oncology (2024)
P1.02A.01 ADAR1 Regulates Tumorigenesis and Stem Cell Properties in Non-Small Cell Lung Carcinoma
Authors: B.A. Jacobson, S. Tao, A. Sehgal, R. Khadilkar, R.A. Kratzke, M. Patel, H. Saveraid, K. Lan, J. Lan, A. Dolezal
Journal: Journal of Thoracic Oncology (2024)
P1.01C.02 Tobacco Control and Smoking Cessation-related Content in Oncology Meetings: A Scoping Review
Authors: S. Choi, A. Alghabban, J. Do, W. Boateng, D. Chen, R.S. Huang, M. Khan, N.K. Quartey, S. Raman, M.E. Giuliani, W.K. Evans, L. Eng
Journal: Journal of Thoracic Oncology (2024)
MA19.08 Transcriptomic Features of Circulating CX3CR1+CD8+ Temra Cells as a Predictor of Chemo-Immunotherapy Response in NSCLC Patients
Authors: J. Wu, X. Xu, H. Si, Y. Li, L. Xu, Y. She, X. Hu, C. Chen, Y. Dong
Journal: Journal of Thoracic Oncology (2024)
P1.01C.03 The Influence of Smoking on Morbidity and Early Mortality after Anatomical Lung Resections for Stage I-IIIA NSCLC
Authors: K. Grapatsas, F. Doerr, F. Oezkan, N. Baldes, D. Theegarten, K. Darwiche, W. Eberhardt, T. Gauler, M. Stuschke, H. Hautzel, K. Herrmann, C. Taube, M. Forsting, M. Schuler, S. Bölükbas
Journal: Journal of Thoracic Oncology (2024)
MA15.08 Ultrasensitive Blood Test for Early Lung Cancer: Integrating Fragmentomics and Mutational Signatures in cfDNA
Authors: J. He, H. Wang, Y. Feng, J. Li, P. Chen, X. Zheng, W. Fu, C. Li, S. Tang, H. Bao, M. Wu, S. Chang, D. Zhu, S. Yang, Y. Shao, R. Yin, W. Liang
Journal: Journal of Thoracic Oncology (2024)
MA18.04 Evaluating Early-Stage Lung Cancer Survival Based on Age and Morbidity to Inform the Upper Age Limit for Screening
Authors: M.T. Warkentin, E. Vakil, E.L.R. Bedard, W.Y. Cheung, D.R. Brenner, A. Tremblay
Journal: Journal of Thoracic Oncology (2024)
MA07.06 Eradicating Drug Tolerant Persisters (DTPs) In EGFR-Mutated Non Small Cell Lung Cancer (NSCLC) By Targeting TROP2
Authors: S. Baldacci, E.J. Brea, F. Facchinetti, S. Malhotra, M. Tolstorukov, M. Booker, Z. Li, S. Chakravarti, F. Lococo, S. D’Agnelli, L. Gnetti, A. Leonetti, W.W. Feng, J.A. Tsai, A.-V. Hartley, M.-A. Locquet, J.V. Alessi, M.M. Awad, C. Lau, A. Saldanha, P. Chopade, S. Kivlehan, K. Ngo, P. Lizotte, E. Ivanova, P. Gokhale, C. Paweletz, E.L. Smith, P.A. Jänne, D.A. Barbie
Journal: Journal of Thoracic Oncology (2024)
MA05.07 Pretreatment with Cisplatin or Radiation Therapy Enhances CAR T-Cell Therapy Efficacy
Authors: R. Bellis, M.S. Skovgard, H.T. Quach, A. De Biasi, J. Villena-Vargas, P.S. Adusumilli
Journal: Journal of Thoracic Oncology (2024)
MA08.11 Incidental Lung Nodule Program: A New Approach for Early Detection and Management of Lung Cancer
Authors: J.J. Zulueta, N.J. Ayoub, H.Y. Wang, J. Qi, S. Adler, S. Chen, S. Lim, S. Luby, A. Velo, M. Sangro
Journal: Journal of Thoracic Oncology (2024)
MA06.12 Updated Efficacy, Safety, and Biomarker Analysis in Patients with TRK Fusion Lung Cancer Treated with Larotrectinib
Authors: J.J. Lin, D.S.W. Tan, S. Kummar, V. Moreno, S. Leyvraz, B. Dubashi, H. Parambath, D.-I. Burcoveanu, N. Neu, S. Leserer, H. Seidel, C.E. Mussi, L. Shen, A. Drilon
Journal: Journal of Thoracic Oncology (2024)
MA04.08 High Recruitment Rate and Performance of a National Lung Cancer Screening Network Implementing Web-Based Instruments
Authors: M. Balbi, C. Battiloro, G. Besutti, M. Caterino, F. Caumo, E. Cavigli, A.F. De Filippis, G. Di Nardo, D. Galetta, C.M.S. Ierna, E. Mercadante, G. Milanese, G.L. Pariscenti, U. Pastorino, S. Sironi
Journal: Journal of Thoracic Oncology (2024)
MA09.03 Plasma Proteomics-based Models for Predicting Immunotherapy- and Chemotherapy-Related Toxicity in NSCLC Patients
Authors: J. Naidoo, D.R. Gandara, R.R. Sullivan, Y.K. Chae, D. Carbone, P. Christopoulos, N. Reinmuth, I. Koch, I. Puzanov, J. Bar, I. Kamer, M. Moskovitz, A. Levy-Barda, A. Agbarya, A. Zer, M. Gottfried, M. Abu Amna, S. Brown, M. Lotem, G. Price, A. Hassani, T. Harkovsky, R. Leibowitz, I. Sela, C. Lahav, B. Yellin, M. Harel, Y. Elon
Journal: Journal of Thoracic Oncology (2024)